Effects of Su Jok Therapy on Pain, Fatigue, Nausea-Vomiting and Spiritual Well-Being
Launched by MUŞ ALPARSLAN UNIVERSITY · Jul 29, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called sujok therapy on patients with cancer who are receiving chemotherapy. The researchers want to find out if sujok therapy can help reduce pain, fatigue, and nausea or vomiting, as well as improve spiritual well-being. Sujok therapy involves applying pressure to specific points on the hands and feet, and the goal is to see if this can make a positive difference for patients during their treatment.
To participate in this study, you need to be at least 18 years old, have a cancer diagnosis, and be currently undergoing chemotherapy. It's important that participants can communicate well and complete the necessary forms. Unfortunately, if someone’s health deteriorates or they decide to withdraw from the study, they will not be able to continue. The trial is currently not recruiting participants, but if you meet the criteria and are interested, this could be a chance to explore how sujok therapy might help with some of the challenges of cancer treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being over 18 years old
- • Being diagnosed with cancer
- • Being receiving chemotherapy
- • No communication problems
- Exclusion Criteria:
- • Deterioration or death during the research process
- • Requesting to withdraw from the research
- • Incomplete filling of forms
About Muş Alparslan University
Muş Alparslan University is a distinguished academic institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university is committed to fostering innovative research initiatives that contribute to the understanding and treatment of medical conditions. By leveraging its academic resources, expertise, and collaborative partnerships, Muş Alparslan University aims to ensure the highest standards of scientific rigor and ethical conduct in clinical trials, ultimately enhancing patient care and contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported